Communications to Healthcare Providers
2023
2022
- COVID-19 Antiviral Treatments
- Health Advisory: Respiratory Syncytial Virus (RSV)
- 2021 Tuberculosis Information for Risk Assessment 02-07-22
- Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology
- Health Advisory- Syphilis
- Health Advisory- Monkey Pox
- Monkeypox Testing Basics
- Communicable Disease Reporting 10-18-2022
2021
2020
- Updated Gonorrhea Treatment Recommendations 12-30-20
- Coronavirus (COVID-19) Advisory 03-06-2020
- Coronavirus (COVID-19) Pre-Pandemic Planning 02-27-2020
- Disseminated Gonococcal Infection Cluster Investigation 02-26-2020
- Coronavirus Situation Summary 01-31-2020
- Interim Guidance on Outbreak of 2019 Novel Coronavirus (2019-nCoV) 01-24-2020 - OBSOLETE
2019
- Permethrin 5% Stock 12-10-19
- Gonorrhea now at urgent-threat level; mycoplasma genitlium concerns on the rise 11-21-19
- MDHHS Offers Student Loan Repayment to Medical Professionals Who Treat Opioid Use Disorder 11-14-19
- Healthcare Provider Role in Diagnosis and Surveillance of Vaccine Preventable Diseases 10-10-19
- Eastern Equine Encephalitis Risk 09-19-19
- Vaping Associated Pulmonary Illness 09-03-19
- Legionellosis Awareness 08-21-19
- Swine Flu 08-02-19
- Psittacosis Awareness 07-03-19
- Legionellosis Awareness 05-28-19
- Confirmed Measles 05-17-19
- Measles Screening and Specimen Collection 04-30-19
- Increased Surveillance for Measles 03-28-19
- Increased Surveillance for Mumps 03-20-19
- 2018 Tuberculosis Information for Risk Assessment 01-16-19
- Norovirus 01-08-19
2018
2017
2016
2015